The catastrophic antiphospholipid syndrome: A review of pathogenesis, clinical features and treatment

Israel Medical Association Journal

Volumn 2, Issue 4, 2000, Pages 268-273

  Asherson, R A ^a   Cervera, R ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Adrenalin insufficiency; Anti 2 glycoprotein 1; Anticardiolipin antibodies; Antiphospholipid syndrome

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEFIBROTIDE; FIBRINOLYTIC AGENT; GAMMA INTERFERON; HEPARIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; METALLOPROTEINASE; METHYLPREDNISOLONE; PENTOXIFYLLINE; PROSTACYCLIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR; WARFARIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIPHOSPHOLIPID SYNDROME; B LYMPHOCYTE ACTIVATION; BACTERIAL INFECTION; BLEEDING; BLOOD TRANSFUSION; CYTOKINE RELEASE; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG WITHDRAWAL; HUMAN; KIDNEY INFARCTION; LIVEDO RETICULARIS; MICROANGIOPATHY; MULTIPLE ORGAN FAILURE; NONHUMAN; PLASMAPHERESIS; PROTEIN DEFICIENCY; REVIEW; THROMBOPHILIA; THROMBOSIS;

ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; MULTIPLE ORGAN FAILURE; THROMBOSIS;

EID: 0033843153     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. The catastrophic antiphospholipid syndrome
2. The catastrophic antiphospholipid syndrome 1996: Acute multi-organ failure associated with antiphospholipid antibodies. A review of 31 patients
3. The 'catastrophic' antiphospholipid syndrome. Clinical and laboratory features of 50 patients
4. The 'primary' antiphospholipid syndrome. Major clinical and serological features
5. Catastrophic antiphospholipid antibodies syndrome in primary systemic sclerosis
6. An unusual syndrome of devastating non-inflammatory vasculopathy associated with anticardiolipin antibodies. A report of two cases
7. Catastrophic antiphospholipid syndrome with fatal course in rheumatoid arthritis
8. Guidelines on the investigation and management of thrombophilia
9. Anticardiolipin antibodies, recurrent thrombosis and Warfarin withdrawal
10. Thrombotic storm: When thrombosis begets thrombosis
11. Systemic lupus erythematosus associated with catastrophic antiphospholipid syndrome occurring after typhoid fever. A possible role of salmonella lipopolysaccharide in the occurrence of diffuse vasculopathy/coagulopathy
12. Catastrophic antiphospholipid syndrome. Clinical description and triggering factors in eight patients
13. Three episodes of acute multi-organ failure in a women with secondary antiphospholipid syndrome
14. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome - molecular mimicry
15. Origin of antiphospholipid antibodies: Induction of aPL by viral peptides
16. Activation of cultured vascular endothelial cells by antiphospholipid antibodies
17. Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonucleoleucocytes, monocytes and related leucocytes cell lines
18. Induction of tissue factor on monocytes by adhesion to endothelial cells
19. Induction of tissue factor-like activity in monocytes by anticardiolipin antibodies
20. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus
21. Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS)
22. Multimers and metalloproteases
23. Severe acute multi-organ complications in the 'primary' antiphospholipid syndrome: It is appropriate to use the 'catastrophic' adjective
24. Multiorgan thrombotic disorder in systemic lupus erythematosus. A common link?
25. The pathophysiology and management of thrombotic thrombocytopenic purpura
26. Thrombotic thrombocytopenic purpura/haemolytic uremic syndrome relapse: Frequency, pathogenesis and meaning
27. Disseminated intravascular coagulation: Clinical and laboratory aspects
28. Relapsing catastrophic antiphospholipid antibody syndrome: A mimic for thrombocytopenic purpura
29. Occult pulmonary embolism presenting with thrombocytopenia and elevated fibrin split products
30. Catastrophic antiphospholipid syndrome. Response to repeated plasmapheresis over three years
31. Therapeutic use of single stranded naked, denatured DNA (Defibritide, DF) in antiphospholipid antibody syndrome (APLAS)